BIOMAT Database Logo BIOMAT Database Logo

Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. 2003

Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
The Third Department of Internal Medicine, Gifu University School of Medicine, Tsukasa-machi 40, Gifu 500-8705, Japan.

Dehydroepiandrosterone (DHEA) is expected to have a weight-reducing effect. In this study, we evaluated the effect of DHEA on genetically obese Otsuka Long Evans Fatty rats (OLETF) compared with Long-Evans Tokushima rats (LETO) as control. Feeding with 0.4% DHEA-containing food for 2 wk reduced the weight of sc, epididymal, and perirenal adipose tissue in association with decreased plasma leptin levels in OLETF. Adipose tissue from OLETF showed increased expression of peroxisome proliferator-activated receptor gamma (PPARgamma) protein, which was prevented by DHEA treatment. Further, we examined the effect of DHEA on PPARgamma in primary cultured adipocytes and monolayer adipocytes differentiated from rat preadipocytes. PPARgamma protein level was decreased in a time- and concentration-dependent manner, and DHEA significantly reduced mRNA levels of PPARgamma, adipocyte lipid-binding protein, and sterol regulatory element-binding protein, but not CCAAT/enhancer binding protein alpha. DHEA-sulfate also reduced the PPARgamma protein, but dexamethasone, testosterone, or androstenedione did not alter its expression. In addition, treatment with DHEA for 5 d reduced the triglyceride content in monolayer adipocytes. These results suggest that DHEA down-regulates adiposity through the reduction of PPARgamma in adipocytes.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets

Related Publications

Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes.
March 2004, The Journal of biological chemistry,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes.
April 1999, Diabetes,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Down-regulation of peroxisome proliferator-activated receptor-gamma gene expression by sphingomyelins.
March 2001, FEBS letters,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Peroxisome proliferator-activated receptor-gamma expression in lung.
July 2002, Chest,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes.
January 2012, Peptides,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1.
October 2008, The Journal of biological chemistry,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
[Expression of peroxisome proliferator-activated receptor gamma in glioma].
March 2008, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Peroxisome proliferator-activated receptor gamma (PPARĪ³) regulates lactase expression and activity in the gut.
November 2017, EMBO molecular medicine,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes.
March 2001, The Journal of biological chemistry,
Kazuo Kajita, and Tatsuo Ishizuka, and Tomoatsu Mune, and Atsushi Miura, and Masayoshi Ishizawa, and Yoshinori Kanoh, and Yasunori Kawai, and Yoshiyuki Natsume, and Keigo Yasuda
Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation.
June 2001, American journal of respiratory cell and molecular biology,
Copied contents to your clipboard!